| Forced degradation studies to assess the stability of drugs and products S Singh, M Junwal, G Modhe, H Tiwari, M Kurmi, N Parashar, P Sidduri TrAC Trends in Analytical Chemistry 49, 71-88, 2013 | 247 | 2013 |
| Quality by design (QbD) in analytical sciences: an overview H Bhutani, M Kurmi, S Singh, S Beg, B Singh Quality Assurance 3, 39-45, 2004 | 115 | 2004 |
| Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide M Kurmi, S Kumar, B Singh, S Singh Journal of pharmaceutical and biomedical analysis 96, 135-143, 2014 | 73 | 2014 |
| Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its … VM Golla, M Kurmi, K Shaik, S Singh Journal of pharmaceutical and biomedical analysis 131, 146-155, 2016 | 61 | 2016 |
| Stability behaviour of antiretroviral drugs and their combinations. 5: Characterization of novel degradation products of abacavir sulfate by mass and nuclear magnetic resonance … M Kurmi, A Sahu, S Singh Journal of pharmaceutical and biomedical analysis 134, 372-384, 2017 | 29 | 2017 |
| Stability behaviour of antiretroviral drugs and their combinations. 1: characterization of tenofovir disoproxil fumarate degradation products by mass spectrometry M Kurmi, VM Golla, S Kumar, A Sahu, S Singh RSC Advances 5 (116), 96117-96129, 2015 | 23 | 2015 |
| Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid … M Kurmi, K Jayaraman, S Natarajan, GS Kumar, H Bhutani, L Bajpai Journal of Chromatography A 1625, 461257, 2020 | 20 | 2020 |
| Stability behaviour of antiretroviral drugs and their combinations. 8: Characterization and in-silico toxicity prediction of degradation products of efavirenz M Kurmi, A Sahu, DK Singh, IP Singh, S Singh Journal of Pharmaceutical and Biomedical Analysis 148, 170-181, 2018 | 20 | 2018 |
| Stability behaviour of antiretroviral drugs and their combinations. 2: characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR … M Kurmi, BS Kushwah, A Sahu, M Narayanam, S Singh Journal of Pharmaceutical and Biomedical Analysis 125, 245-259, 2016 | 20 | 2016 |
| Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry A Sahu, M Narayanam, M Kurmi, MK Ladumor, S Singh Magnetic Resonance in Chemistry 54 (8), 632-636, 2016 | 17 | 2016 |
| Stability behaviour of antiretroviral drugs and their combinations. 3: Characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass … M Kurmi, DK Singh, S Tiwari, P Sharma, S Singh Journal of Pharmaceutical and Biomedical Analysis 128, 438-446, 2016 | 16 | 2016 |
| LC–MS/TOF, LC–MSn and H/D Exchange Studies on Solifenacin Succinate Targeted to Characterize its Forced Degradation Products DK Singh, M Kurmi, T Handa, S Singh Chromatographia 79, 159-168, 2016 | 16 | 2016 |
| Stability behavior of antiretroviral drugs and their combinations. 7: Comparative degradation pathways of lamivudine and emtricitabine and explanation to their differential … M Kurmi, S Singh Journal of Pharmaceutical and Biomedical Analysis 142, 155-161, 2017 | 15 | 2017 |
| Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients M Kurmi, A Sahu, MK Ladumor, AK Bansal, S Singh Journal of Pharmaceutical and Biomedical Analysis 166, 174-182, 2019 | 12 | 2019 |
| Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 … M Kurmi, A Sahu, A Balhara, IP Singh, S Kulkarni, NK Singh, P Garg, ... Journal of Pharmaceutical and Biomedical Analysis 178, 112911, 2020 | 11 | 2020 |
| Characterization of forced degradation products of torasemide through MS tools and explanation of unusual losses observed during mass fragmentation of drug and degradation … M Kurmi, N Patel, S Jhajra, PV Bharatam, S Singh Journal of Pharmaceutical and Biomedical Analysis 145, 209-218, 2017 | 11 | 2017 |
| Stability behaviour of antiretroviral drugs and their combinations. 6: evidence of formation of potentially toxic degradation products of zidovudine under hydrolytic and … M Kurmi, A Sahu, SK Tiwari, S Singh Rsc Advances 7 (30), 18803-18814, 2017 | 11 | 2017 |
| Characterization of solution stress degradation products of aliskiren and prediction of their physicochemical and ADMET properties BS Kushwah, J Gupta, DK Singh, M Kurmi, A Sahu, S Singh European Journal of Pharmaceutical Sciences 121, 139-154, 2018 | 10 | 2018 |
| Successful development by design of experiments of a gas chromatography method for simultaneous analysis of residual solvents of classes 1 and 2 KP Shah, S Kumar, M Kurmi, D Gohil, S Singh Journal of Chromatographic Science 56 (6), 473-479, 2018 | 7 | 2018 |
| Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG 2000) and identification of its degradation products M Kurmi, V Suryavanshi, NS Panduranga, K Jayaraman, L Bajpai, W Fish, ... Journal of Pharmaceutical and Biomedical Analysis 198, 113967, 2021 | 6 | 2021 |
Saranjit SinghNational Institute of Pharmaceutical Education and ResearchVerified email at niper.ac.in